• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于测定生物和水性基质中头孢洛扎/他唑巴坦的高效液相色谱法的开发。

Development of an HPLC Method for the Determination of Ceftolozane/Tazobactam in Biological and Aqueous Matrixes.

作者信息

Sutherland Christina A, Nicolau David P

机构信息

Center for Anti-Infective Research and Development, Hartford Hospital, 80 Seymour Street, Hartford, CT 06102, USA.

Center for Anti-Infective Research and Development, Hartford Hospital, 80 Seymour Street, Hartford, CT 06102, USA Division of Infectious Diseases, Hartford Hospital, Hartford, CT, USA

出版信息

J Chromatogr Sci. 2016 Jul;54(6):1037-40. doi: 10.1093/chromsci/bmw047. Epub 2016 Apr 4.

DOI:10.1093/chromsci/bmw047
PMID:27048639
Abstract

Herein, we report the development and validation of an HPLC method to analyze ceftolozane and tazobactam simultaneously in human plasma, human serum, swine serum and saline matrixes. A reversed-phase column was used with a UV detector set at 260 nm and switched to 218 nm. The mobile phase consisted of methanol and sodium phosphate buffer at a flow rate of 1.1 mL/min. Cefepime was used as the internal standard. The standard curves were linear over a range of 0.4-50 μg/mL. This methodology represents a simple, reproducible approach to the determination of drug concentrations with sufficient accuracy and precision for pharmacokinetic studies undertaken with this recently FDA-approved antimicrobial therapy.

摘要

在此,我们报告了一种高效液相色谱法的开发与验证,该方法可同时分析人血浆、人血清、猪血清和生理盐水基质中的头孢洛扎和他唑巴坦。使用反相柱,紫外检测器设置在260 nm,并切换至218 nm。流动相由甲醇和磷酸钠缓冲液组成,流速为1.1 mL/min。头孢吡肟用作内标。标准曲线在0.4 - 50 μg/mL范围内呈线性。该方法是一种简单、可重复的测定药物浓度的方法,对于采用这种最近获得FDA批准的抗菌治疗进行的药代动力学研究具有足够的准确性和精密度。

相似文献

1
Development of an HPLC Method for the Determination of Ceftolozane/Tazobactam in Biological and Aqueous Matrixes.一种用于测定生物和水性基质中头孢洛扎/他唑巴坦的高效液相色谱法的开发。
J Chromatogr Sci. 2016 Jul;54(6):1037-40. doi: 10.1093/chromsci/bmw047. Epub 2016 Apr 4.
2
Validated HPLC-UV detection method for the simultaneous determination of ceftolozane and tazobactam in human plasma.用于同时测定人血浆中头孢洛扎和他唑巴坦的经过验证的高效液相色谱-紫外检测方法。
Bioanalysis. 2018 Apr 1;10(7):461-473. doi: 10.4155/bio-2017-0257. Epub 2018 Apr 10.
3
Development of an HPLC-MS/MS method for the determination of ceftolozane/tazobactam in bronchoalveolar lavage fluid.建立一种用于测定支气管肺泡灌洗液中头孢洛扎/他唑巴坦的高效液相色谱-串联质谱法。
Future Sci OA. 2018 Nov 15;5(1):FSO352. doi: 10.4155/fsoa-2018-0079. eCollection 2019 Jan.
4
Quantitation and stability of piperacillin and tazobactam in plasma and ultrafiltrate from patients undergoing continuous venovenous hemofiltration by HPLC.通过高效液相色谱法测定接受持续静脉-静脉血液滤过治疗的患者血浆和超滤液中哌拉西林和他唑巴坦的含量及稳定性。
Biomed Chromatogr. 2005 Oct;19(8):570-8. doi: 10.1002/bmc.482.
5
A green capillary zone electrophoresis method for the simultaneous determination of piperacillin, tazobactam and cefepime in pharmaceutical formulations and human plasma.一种用于同时测定药物制剂和人血浆中哌拉西林、他唑巴坦和头孢吡肟的绿色毛细管电泳法。
Biomed Chromatogr. 2015 Dec;29(12):1811-8. doi: 10.1002/bmc.3500. Epub 2015 Jun 8.
6
Development of an HPLC Method for the Determination of Meropenem/Vaborbactam in Biological and Aqueous Matrixes.建立 HPLC 法测定生物和水性基质中美罗培南/沃诺拉赞的含量。
J Chromatogr Sci. 2020 Aug 21;58(8):726-730. doi: 10.1093/chromsci/bmaa041.
7
Development of an HPLC method for the determination of anidulafungin in human plasma and saline.开发一种用于测定人血浆和盐水中阿尼芬净的高效液相色谱法。
J Chromatogr Sci. 2011 May;49(5):397-400. doi: 10.1093/chromsci/49.5.397.
8
Determination of total and free ceftolozane and tazobactam in human plasma and interstitial fluid by HPLC-UV.采用高效液相色谱-紫外法测定人血浆和间质液中的总头孢洛扎纳和他唑巴坦。
J Pharm Biomed Anal. 2019 Jan 30;163:34-38. doi: 10.1016/j.jpba.2018.09.044. Epub 2018 Sep 24.
9
Pharmacokinetics and Tissue Penetration of Ceftolozane-Tazobactam in Diabetic Patients with Lower Limb Infections and Healthy Adult Volunteers.头孢洛扎他唑巴坦在下肢感染的糖尿病患者和健康成年志愿者中的药代动力学和组织穿透性。
Antimicrob Agents Chemother. 2017 Nov 22;61(12). doi: 10.1128/AAC.01449-17. Print 2017 Dec.
10
An improved high-performance liquid chromatographic method with a solid-phase extraction for the determination of piperacillin and tazobactam: application to pharmacokinetic study of different dosage in Chinese healthy volunteers.一种改进的高效液相色谱法结合固相萃取用于哌拉西林和他唑巴坦的测定:在中国健康志愿者中不同剂量的药代动力学研究中的应用
Biomed Chromatogr. 2007 Jul;21(7):680-6. doi: 10.1002/bmc.800.

引用本文的文献

1
Ceftolozane-Tazobactam Pharmacokinetics in the Abdominal Tissue of Patients Undergoing Lower Gastrointestinal Surgery: Dosing Considerations Based on Site-Specific Pharmacodynamic Target Attainment.头孢托罗-他唑巴坦在下消化道手术患者腹部组织中的药代动力学:基于部位特异性药效学靶点达到情况的给药考量
Infect Dis Ther. 2023 Jan;12(1):193-207. doi: 10.1007/s40121-022-00720-x. Epub 2022 Nov 24.
2
Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant : In Vivo and In Vitro Evidence.亚胺培南/西司他丁(CAZ-AVI)的亚最佳浓度可能会在广泛耐药菌中选择出对CAZ-AVI的耐药性:体内和体外证据。
Antibiotics (Basel). 2022 Oct 22;11(11):1456. doi: 10.3390/antibiotics11111456.
3
Comparison of Ceftolozane/Tazobactam Infusion Regimens in a Hollow-Fiber Infection Model against Extensively Drug-Resistant Pseudomonas aeruginosa Isolates.
比较头孢他啶/他唑巴坦输注方案在中空纤维感染模型中对广泛耐药铜绿假单胞菌分离株的疗效。
Microbiol Spectr. 2022 Jun 29;10(3):e0089222. doi: 10.1128/spectrum.00892-22. Epub 2022 Jun 13.
4
Impact of ceftolozane/tazobactam concentrations in continuous infusion against extensively drug-resistant Pseudomonas aeruginosa isolates in a hollow-fiber infection model.在中空纤维感染模型中,头孢他啶/他唑巴坦连续输注浓度对广泛耐药铜绿假单胞菌分离株的影响。
Sci Rep. 2021 Nov 12;11(1):22178. doi: 10.1038/s41598-021-01784-4.
5
A Novel Dosing Strategy of Ceftolozane/Tazobactam in a Patient Receiving Intermittent Hemodialysis.头孢洛扎/他唑巴坦在接受间歇性血液透析患者中的一种新型给药策略
Open Forum Infect Dis. 2021 May 12;8(6):ofab238. doi: 10.1093/ofid/ofab238. eCollection 2021 Jun.
6
Plasma and Cerebrospinal Fluid Therapeutic Drug Monitoring of Ceftolozane and Tazobactam During Treatment of Multidrug-Resistant Meningitis.多药耐药性脑膜炎治疗期间头孢洛扎与他唑巴坦的血浆和脑脊液治疗药物监测
Open Forum Infect Dis. 2020 Nov 12;7(12):ofaa549. doi: 10.1093/ofid/ofaa549. eCollection 2020 Dec.
7
Short-Term Effects of Appropriate Empirical Antimicrobial Treatment with Ceftolozane/Tazobactam in a Swine Model of Nosocomial Pneumonia.适宜经验性抗菌治疗头孢洛扎/他唑巴坦对院内获得性肺炎猪模型短期疗效的影响。
Antimicrob Agents Chemother. 2021 Jan 20;65(2). doi: 10.1128/AAC.01899-20.
8
Ceftolozane/tazobactam for pulmonary exacerbation in a 63-year-old cystic fibrosis patient with renal insufficiency and an elevated MIC to .头孢洛扎/他唑巴坦用于一名63岁患有肾功能不全且对……的最低抑菌浓度升高的囊性纤维化患者的肺部加重期治疗
IDCases. 2020 May 18;21:e00830. doi: 10.1016/j.idcr.2020.e00830. eCollection 2020.
9
Efficacy of Ceftolozane-Tazobactam in Combination with Colistin against Extensively Drug-Resistant Pseudomonas aeruginosa, Including High-Risk Clones, in an Pharmacodynamic Model.头孢洛扎-他唑巴坦与黏菌素联合用药在药效学模型中对包括高风险克隆在内的广泛耐药铜绿假单胞菌的疗效
Antimicrob Agents Chemother. 2020 Mar 24;64(4). doi: 10.1128/AAC.02542-19.
10
Ceftolozane-Tazobactam in the Treatment of Experimental Pseudomonas aeruginosa Pneumonia in Persistently Neutropenic Rabbits: Impact on Strains with Genetically Defined Mechanisms of Resistance.头孢洛扎他唑巴坦治疗持续性中性粒细胞减少兔实验性铜绿假单胞菌肺炎:对具有遗传耐药机制的菌株的影响。
Antimicrob Agents Chemother. 2019 Aug 23;63(9). doi: 10.1128/AAC.00344-19. Print 2019 Sep.